Discussion about this post

User's avatar
Your Nextdoor PCP's avatar

This resonates hard. From a physician-scientist perspective, what you’re describing is the classic “unregulated supplement market” problem, except the substrate is context budget and the adverse effect is cognitive impairment of the agent (hallucination, goal drift, brittle behavior) rather than liver enzymes.

A few parallels that feel useful:

1. Skills need a dosage form + labeling. Token count is dose, and right now we’re handing people 4,000-token “capsules” that claim to be “concise” while quietly consuming a meaningful fraction of effective context. Your <150-line rule reads like a safety standard. 

2. We’re missing the equivalent of pharmacovigilance. The market is optimizing for “exists on GitHub” not “improves outcomes.” What we need is post-market surveillance: regression tests for agent behavior, A/B evals, and public “side effect” reporting (when a skill reliably increases error rate). 

3. Curation beats indexing. A package manager that surfaces trustworthy skills (with benchmarks, failure modes, and versioning) is basically an FDA + formulary + Cochrane combo for agent workflows and your point about the trust gap is spot on. 

Love the “description = when to use” reframing, and the emphasis on thin integrations where the tool does the talking.

matt wilkie's avatar

"There is a need for an AI ... package manager that is an ecosystem backbone, one that does a good job surfacing the best tools instead of simply indexing all of them without care for quality. ...the big players have dropped the ball and left a big gap to fill."

100 percent. Thanks for articulating this problem and resultant frustration so clearly, AND a first crack at mitigation that's worth exploring.

9 more comments...

No posts

Ready for more?